Analystreport

Seres Therapeutics, Inc. (NASDAQ: MCRB) was downgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "sell" rating.

Seres Therapeutics, Inc.  (MCRB) 
Last seres therapeutics, inc. earnings: 11/5 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.serestherapeutics.com